NCT02003456View on ClinicalTrials.gov

Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Ischemic Heart DiseaseMyocardial Infarction
Interventions
DRUG

Cardiac PET scan w/18F-Fluorodeoxyglucose and rubidium-82

Study subjects will undergo a Cardiac PET scan that will take approximately 20 minutes to complete. In addition to standard clinical rubidium-82/18F-fluorodeoxyglucose (FDG) PET imaging, during a separate imaging session, participants will be infused with a second dose of the radio-tracer rubidium-82 during FDG imaging scan that will take an additional 10 to 15 minutes to complete.

Trial Locations (1)

48109

University of Michigan Hospital, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT02003456 - Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging | Biotech Hunter | Biotech Hunter